Utrogestan Vaginal^® 200mg Capsules is indicated for supplementation of the luteal phase during Assisted Reproductive Technology (ART) cycles. The recommended dose is 600 mg/day in three divided doses, inserted deep into the vagina, from the day of embryo transfer until at least the 7th week of pregnancy and not later than the 12th week of pregnancy.

Vaginal progesterone tablets such as Utrogestan Vaginal® are used in 44% of IVF cycles worldwide¹. The product has similar clinical pregnancy rate to intramuscular progesterone² and is supplied with 21 disposable applicators enabling the capsule to be inserted deep into the vagina as required. This local administration offers rapid absorption where it’s needed³.

To ensure those who prescribed the treatment know how to administer the medical and most important gain confidence from knowing how its helping them, Besins Healthcare has developed a range of patient support material which includes an illustrative brochure, an app for smart phones/mobile devices and a website. The instruction on the capsule box provides simple instruction on how to view the website and download the app.

Below is a link to the Summary of product Characteristics (SPC) & Patient Information Leaflet (PIL) which will provide you with more information on the product.

https://www.medicines.org.uk/emc/